Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
[Provision of alemtuzumab safety is one of the main components of pharmacovigilance]. [electronic resource] by
- Khachanova, N V
- Bakhtiyarova, K Z
- Boyko, A N
- Vlasov, Ya V
- Davydovskaia, M V
- Evdoshenko, E P
- Zakharova, M N
- Malkova, N A
- Sivertseva, S A
- Spirin, N N
- Stolyarov, I D
- Schmidt, T E
- Khabirov, F A
Producer: 20190531
In:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 118
Availability: No items available.
|
|
|
16.
|
[Clinical recommendations on the use of alemtuzumab (lemtrada)]. [electronic resource] by
- Alifirova, V M
- Bisaga, G N
- Boyko, A N
- Bryukhov, V V
- Davydovskay, M V
- Zakharova, M N
- Zakharova, E V
- Malkova, N A
- Popova, E V
- Salogub, G N
- Sivertseva, S A
- Troshina, E A
- Khachanova, N V
- Schmidt, T E
Producer: 20190408
In:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 117
Availability: No items available.
|